JEWELL MARIE CONWAY

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family LEESBURG, FL NPI 1184227779

General Payments — all program years on this page

$1,665.46

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 92
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $401.65 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $401.6519

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $297.9221
2022 $238.3013
2023 $727.5939
2024 $401.6519

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1086349571 Bayer Healthcare Pharmaceuticals Inc. $16.51 11/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086647149 Novartis Pharmaceuticals Corporation $17.64 01/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1086647153 Novartis Pharmaceuticals Corporation $14.93 02/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1100223720 Novo Nordisk Inc $19.52 05/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104386327 AstraZeneca Pharmaceuticals LP $13.68 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104470680 AstraZeneca Pharmaceuticals LP $13.71 04/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105484691 AstraZeneca Pharmaceuticals LP $13.33 02/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1105596767 AstraZeneca Pharmaceuticals LP $17.42 02/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106946838 ABBVIE INC. $15.50 03/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106946840 ABBVIE INC. $19.32 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106946842 ABBVIE INC. $12.58 05/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1106946844 ABBVIE INC. $90.70 06/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116380600 GlaxoSmithKline, LLC. $22.15 01/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116564440 GlaxoSmithKline, LLC. $21.25 04/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119049032 Otsuka America Pharmaceutical, Inc. $22.72 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1130961822 PFIZER INC. $18.48 01/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1139481340 Astellas Pharma US Inc $23.07 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141924490 Merck Sharp & Dohme LLC $14.14 07/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1153428097 Salix Pharmaceuticals, a division of Bausch Health US, LLC $15.00 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.